Skip to NavigationSkip to content

Pharmafile - Research and Development

New positive data for Janssen's esketamine depression treatment, MSD buys Peloton Therapeutics for $2.1 billion, and Gilead CEO grilled on why its...
New findings from researchers at King’s College London could lead to improved vaccinations against sexually transmitted infections (STIs).
Array Biopharma has revealed new data on its combination of Braftovi, Mektovi, and Erbitux, showing that it met both of its primary endpoints in the...
California biotech Amgen has agreed to buy Danish biopharmaceutical company Nuevolution AB for 1.61 billion Swedish crowns ($166.8 million).

Features

Dr Bill Love, Founder and Chief Scientific Officer of Destiny Pharma, discusses the rise of antimicrobial resistance (AMR), the antibiotic...

Appointments

Rare disease and oncology biopharma firm EUSA Pharma has revealed two new additions to its senior leadership team in two newly-created roles: Dr...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches